Goldpac Group Ltd

  • ISIN: HK0000172855
  • Land: Hong Kong

Nachricht vom 17.02.2017 | 07:58

Building the World-leading Fintech & Data Service Center

EQS-News / 17/02/2017 / 14:58 UTC+8

On 17 February 2017, the world's fourth largest, and China's top ranked
payment solutions provider, Goldpac Group Limited ("Goldpac" or the
"Group", stock code: 03315) announces that the Group has settled the
remaining balance of the consideration of RMB26,669,000 (total) for the
acquisition of the land use right for a parcel of land situated in Zhuhai
City. Situated in the west of Goldpac Tech Park, the land parcel covers an
area of approximately 20,999.56 square meters. The permitted land use for
the Land Parcel is for new industry related use with a land use right of
50 years. 

Mr. HOU Ping, CEO of Goldpac, said, "As the pioneer of financial data
processing services in China, Goldpac adheres to the philosophy initiated
by the China government for the development of innovation, coordination,
environmental, open market and sharing of value initiatives when
formulating the Group's overall expansion strategies. In view of the
location and the permitted land use, the Group will construct a
world-leading Fintech and Data Service center, in line with the business
development strategy and plan of the Group by combining new Fintech and
IoT (Internet of Things) technologies to promote the evolution of the
global smart payment industry."


Document: http://n.eqs.com/c/fncls.ssp?u=EAGTRYIRHE
Document title: Building the World-leading Fintech & Data Service Center

17/02/2017 Dissemination of a Press Release, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

Media archive at www.todayir.com

GBC im Fokus

Ergomed PLC: Kursziel angehoben

Die erfolgreiche Wirksamkeitsstudie von Lorediplon zeigt, dass Ergomed PLC eine sehr vielversprechende Co-Development-Pipeline hat. Eine mögliche vorzeitige Auslizenzierungen des Produkts würde dem Unternehmen signifikante Erfolgsbeteiligungen sichern. Deshalb und aufgrund der Anpassung der Wechselkurse erhöhen wir den fairen Wert der Ergomed-Aktie auf 3,41 € je Aktie. Das Rating bleibt KAUFEN.

Aktueller Webcast

XING AG

Preliminary Results 2016

23. Februar 2017

Aktuelle Research-Studie

HELMA Eigenheimbau AG

Original-Research: HELMA Eigenheimbau AG (von GBC AG): Kaufen

24. Februar 2017